Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
| 針對症狀 | Lung Cancer |
| 臨床試驗編號 | NCT00103116 |
| 臨床階段 | Phase II |
| 臨床試驗位址 | Markey Cancer Center |
| 目前研究進度 | This study has been completed. |
| 試驗開始日期 | February 8, 2005 |
| 試驗開始日期 | April 4, 2017 |
| 臨床目的 |
RATIONALE: Vaccines made from a person's white blood cells and allogeneic tumor cells may make the body build an effective immune response to kill tumor cells. PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with stage I, stage II, or stage III non-small cell lung cancer. https://clinicaltrials.gov/ct2/show/NCT00103116?term=DC&recrs=e&cond=lung+cancer&draw=2&rank=4 |